A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Last updated: September 14, 2026
Sponsor: Alnylam Pharmaceuticals
Overall Status: Active - Not Recruiting

Phase

1/2

Condition

Hemophilia

Healthy Volunteers

Treatment

ALN-6400

Placebo

Clinical Study ID

NCT06659640
ALN-6400-001
2025
2025-522510-23-00
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to:

  • evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single ascending doses of ALN-6400 in healthy volunteers

  • evaluate the efficacy, safety, tolerability and PD of multiple doses of ALN-6400 in adult patients with HHT

Eligibility Criteria

Inclusion

Inclusion Criteria -

Part A:

  • Is a healthy adult volunteer

Part B:

  • Is an adult patient with a clinical diagnosis of HHT

Exclusion Criteria -

Part A:

  • Has alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > upper limit of normal (ULN)

  • Has known human immunodeficiency virus (HIV) infection; or known current or chronic hepatitis C virus or hepatitis B virus infection

  • Has an estimated glomerular filtration (eGFR) of <90 mL/min/1.73m^2 at screening

Part B:

  • Has ALT or AST >2×ULN

  • Has total bilirubin >1.5×ULN

  • Has eGFR of <30 mL/min/1.73m^2 at screening

Parts A and B:

  • Is not willing to comply with the contraceptive requirements during the study period

Note: other protocol defined inclusion / exclusion criteria apply

Study Design

Total Participants: 89
Treatment Group(s): 2
Primary Treatment: ALN-6400
Phase: 1/2
Study Start date:
November 07, 2024
Estimated Completion Date:
June 22, 2028

Connect with a study center

  • Clinical Trial Site

    Camperdown, 2050
    Australia

    Site Not Available

  • Clinical Trial Site

    Parkville, 3050
    Australia

    Site Not Available

  • Clinical Trial Site

    Toronto 6167865, Ontario 6093943 M5B 1W8
    Canada

    Site Not Available

  • Clinical Trial Site

    Montreal 6077243,
    Canada

    Active - Recruiting

  • Clinical Trial Site

    Mount Royal, H3P 3P1
    Canada

    Site Not Available

  • Clinical Trial Site

    Toronto, M5B 1W8
    Canada

    Site Not Available

  • Clinical Trial Site

    Bron 3029931, Lyon 69500
    France

    Site Not Available

  • Clinical Trial Site

    Bordeaux, 33000
    France

    Site Not Available

  • Clinical Trial Site

    Bron, 69500
    France

    Site Not Available

  • Clinical Trial Site

    Homburg, 66421
    Germany

    Site Not Available

  • Clinical Trial Site

    L'Hospitalet de Llobregat 3120619, B 8907
    Spain

    Site Not Available

  • Clinical Trial Site

    L'Hospitalet de Llobregat, 8907
    Spain

    Site Not Available

  • Clinical Trial Site

    Birmingham, Alabama 35249
    United States

    Site Not Available

  • Clinical Trial Site

    Cypress, California 90630
    United States

    Site Not Available

  • Clinical Trial Site

    Gainesville, Florida 32608
    United States

    Site Not Available

  • Clinical Trial Site

    Indianapolis, Indiana 46260
    United States

    Site Not Available

  • Clinical Trial Site

    Boston, Massachusetts 02114
    United States

    Site Not Available

  • Clinical Trial Site

    Rochester, Minnesota 55905
    United States

    Site Not Available

  • Clinical Trial Site

    St Louis, Missouri 63110
    United States

    Site Not Available

  • Clinical Trial Site

    Chapel Hill, North Carolina 27514
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.